Phenotypic characteristics of B cells in Behcet's disease: Increased activity in B cell subsets

Journal of Rheumatology

Volumn 26, Issue 4, 1999, Pages 826-832

  Ekşioǧlu Demiralp, Emel ^a   Kibaroǧlu, Alpaslan ^a   Direskeneli, Haner ^a   Yavuz, Şule ^a   Karsli, Fuad ^a   Yurdakul, Sabahattin ^a   Yazici, Hasan ^a   Akoǧlu, Tevfik ^a,b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b MARMARA UNIVERSITY   (Turkey)

Author keywords

Behcet's Disease; CD45RA; CD45RO; CD5+B Lymphocytes

Indexed keywords

ADULT; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; B LYMPHOCYTE; BEHCET DISEASE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; MALE; PRIORITY JOURNAL;

ADULT; AGED; ANTIGENS, CD; ARTHRITIS, RHEUMATOID; B-LYMPHOCYTE SUBSETS; BEHCET SYNDROME; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; SEPSIS;

EID: 2542507876     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Behçet H. Uberrezidivierende aphtose, durch ein Virus verursachte Geschwure am Mund, am Auge und an der Genitalian. Dermatol Wochenschr 1937;105:1152-7.
2. Behçet H. Some observations on the clinical picture of the so-called triple symptom complex. Dermatologica 1940;81:73-81.
3. Emmi L, Salvati G, Brugnola F, Marchione T. Immunopathological aspects of Behçet's disease. Clin Exp Rheumatol 1995;13:687-91.
4. Fuji N, Minagawa T, Nakane A. Spontaneous production of gamma interferon in culture of T lymphocytes obtained from patients with Behçet's disease. J Immunol 1983;130:1683-6.
5. Kahan A, Hamzaoui K, Ayed K. Abnormalities of T lymphocyte subsets in Behçet's disease demonstrated with anti-CD45RA and anti-CD29 monoclonal antibodies. J Rheumatol 1991;19:742-6.
6. Hasan A, Fortune F, Wilson A, et al. Role of gamma delta T cells in pathogenesis and diagnosis of Behçet's disease. Lancet 1996;347:789-94
7. Esin S, Gül A, Hodara V, et al. Peripheral blood T cell expansions in patients with Behçet's disease. Clin Exp Immunol 1997;107:520-7.
8. Charteris DG, Barton K, McCartney ACE, Lightman SL. CD4+ lymphocyte involvement in ocular Behçet's disease. Autoimmunity l992;12;201-6.
9. Mege JL, Dilsen N, Sanguedolce V, et al. Overproduction of monocyte derived tumor necrosis factor α, IL-6, IL-8 and increased neutrophil superoxide generation in Behçet's disease. A comparative study with familial Mediterranean fever and healthy subjects. J Rheumatol 1993;20:1544-9.
10. Takeno M, Kariyone A, Yamashita N, et al. Excessive function of peripheral blood neutrophils from patients with Behçet's disease and from HLA-B51 transgenic mice. Arthritis Rheum 1995;38:426-33.
11. Kaneoka H, Furukawa H, Takeno M, Mizushima Y, Sakane T. HLA-B51 involved in the hyperfunction of peripheral blood neutrophils from patients with Behçet's disease. Rev Med Interne 1993;14 Suppl 1:117s.
12. Pronai L, Ichikawa Y, Nakazawa S, Arimori S. Enhanced superoxide generation and the decreased superoxide scavenging activity of peripheral blood leucocytes in Behçet's disease - effects of colchicine. Clin Exp Rheumatol 1991;9:227-33.
13. Taylor PV, Chamberlain MA, Scott JS. Autoreactivity in patients with Behçet's disease. Br J Rheumatol 1993;32:908-10.
14. Suzuki N, Sakane T, Ueda Y, Tsunematsu T. Abnormal B cell function in patients with Behçet's disease. Arthritis Rheum 1986;29:212-9.
15. Lehner T, Almeida JD, Levinsky RJ. Damaged membrane fragments and immune complexes in the blood of patients with Behçet's syndrome. Clin Exp Immunol 1978;34:206-12.
16. Suzuta T, Amano E, Shimo K. Serological studies on lymphocytotoxic antibodies and immune complexes in sera from Behçet's disease. In: Inaba G. editor. Behçet's disease, pathogenetic mechanism and clinical feature. Proceedings of the International Conference on Behçet's Disease, Tokyo 1981. Tokyo: University of Tokyo Press; 1981:405-11.
17. Hashimoto T, Yanagida T, Okamoto S, Toyama T. Immunochemical properties of circulating immune complexes in Behçet's disease. In: Inaba G, editor. Behçet's disease, pathogenetic mechanism and clinical feature. Proceedings of the International Conference on Behçet's Disease, Tokyo 1981. Tokyo: University of Tokyo Press; 1981:391-403.
18. Direskeneli H, Keser G, D'Cruz D, et al. Anti-endothelial cell antibodies, endothelial proliferation and von Willebrand factor antigen in Behçet's disease. Clin Rheumatol 1995;14:55-61.
19. Akoglu T, Kozakoglu H, Akoglu E. Antibody to intermediate filaments of the cytoskeleton in patients with Behçet's disease. Clin Immunol lmmunopathol 1986;41:427-32.
20. Direskeneli H, Hasan A, Schinnick T, et al. Recognition of B cell epitopes of the 65 kD heat shock protein in Behçet's disease. Scand J Immunol 1996;43:464-71.
21. Alper G, Ozsan H, Girgin F, Onat T, Büyükkeçeci F, Gümüsdis G. Anticardiolipin antibodies in Behçet's disease. In: Wechsler B, Godeau P, editors. Behçet's disease. Proceedings of the 6th International Conference on Behçet's Disease, Paris 1993. Elsevier Science Publishers; 1993:119-122.
22. El-Ramahi KM, Dalaan AA, Sheth K, Kawi MZ, Bohlega S. Antiphospholipid antibodies in Behçet's disease. In: Wechsler B, Godeau P, editors. Behçet's disease. Proceedings of the 6th International Conference on Behçet's Disease, Paris 1993. Elsevier Science Publishers; 1993:109-13.
23. Hardy R, Hayakawa H, Shimuzu M, Yamasaki K, Kishimoto T. Rheumatoid factor secretion from human Ly-1 + B cells. Science 1987;236:77-81.
24. Murakami M, Honjo T. Involvement of B-1 cells in mucosal immunity and autoimmunity. Immunol Today 1995;16:534-8.
25. Smith HR. CD5+ B lymphocytes in systemic lupus erythematosus and rheumatoid arthritis. J Rheumatol 1990;17:441-8.
26. Suzuki N, Sakane T, Engleman EG. Anti-DNA antibody production by CD5+ and CD5-B cells of patients with SLE. J Clin Invest 1990;85:238-47.
27. Zeher M. B cells expressing CD5 in labial salivary glands of patients with primary Sjögren syndrome. Arthritis Rheum 1990;33:453.
28. Kantor AB. The development and repertoire of B-1 cells (CD5 B cells). Immunol Today 1991;12:389-91.
29. Haughton G, Arnold LW, Whithmore AC, Clarke SH. B-1 cells are made, not born. Immunol Today 1993;14:84-7.
30. Morabito F, Prasthofer EF, Dunlap NE, Grossi CE, Tilden AB. Expression of myelomonocytic antigens on chronic lymphocytic leukemia B cells correlates with their ability to produce IL-1. Blood 1987;70:1750-7.
31. Woessner S, Florensa L, Besses C, et al. Immunocytochemical investigation of normal and chronic lymphocytic leukemia lymphocytes reveals unexpectedly frequent reactivity with some myelomonocytic associated antibodies. Leukemia Res 1992; 16:505-10.
32. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group, Blood 1994;84:1361-92.
33. Katoh S, Tominaga A, Migita M, Kudo A, Takatsu A. Conversion of normal Ly-1 positive B lineage cells into Ly-1 positive macrophages in longterm bone marrow cultures. Dev Immunol 1990;1:113-25.
34. Davidson WF, Pierce J, Rudikoff S, Morse HC. Relationships between B cell and myeloid differentiation. Studies with a B lymphocyte progenitor line, HAFTL-1. J Exp Med 1988; 168:389-407.
35. Eksioglu-Demiralp E, Direskeneli H, Sahin S, et al. Increased CD4+ CD 16+ CD4+ CD56+ and CD8+CD11b+ T lymphocytes in Behçet's disease [abstract]. Rev Rhum 1996;7-8:530.
36. Fortune F, Walker J, Lehner T. The expression of T cell receptor and the prevalence of primed, activated and IgA-bound T cells in Behçet's syndrome. Clin Exp Immunol 1990;82:326-32.
37. International Study Group for Behçet's Disease. Criteria for diagnosis of Behçet's desease. Lancet 1990;335:1078-80.
38. Schlossman SF, Boumsell L, Gilk W, editors. Leucocyte Typing. V. White cell differentiation. Antigens. Oxford University Press; 1995. Volume 1.
39. Bergman R, Lorber M, Lerner M, Brik R, Friedman-Birnbaum L. Anticardiolipin antibodies in Behçet's disease. J Dermatol 1990;17:164-7.
40. Murakami M, Honjo T. Involvement of B-1 cells in mucosal immunity and autoimmunity. Immunol Today 1995;16:534-8.
41. Ye YL, Chuang YH, Chiang BL. In vitro and in vivo functional analysis of CD5+ and CD5-B cells of autoimmune NZBxNZW F1 mice. Clin Exp Immunol 1996;106:253-8.
42. Taniguchi O, Miyajima H, Hirano T, et al. The Leu-1 B cell subpopulation in patients with rheumatoid arthritis. J Clin Immunol 1987;7:441-7.
43. Yazici H. The place of Behçet's syndrome among the autoimmune diseases. Intern Rev Immunol 1997;14:1-10.
44. Freedman AS, Freeman G, Horowitz JC, Daley J, Nadler LM. B7, a B-cell restricted antigen that identifies preactivated B cells. J Immunol 1987;139:3260-7.
45. Nabavi N, Freeman G, Gault A, Godfrey D, Nadler LM, Glimcher LH. Signalling through the MHC class II cytoplasmic domain is required for antigen presentation and induces B7 expression. Nature 1992;360:266-8.
46. Freeman GJ, Borriello F, Hodes RJ, et al. Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice. Science 1993;262:907-9.
47. Linsley PS, Clark EA, Ledbetter JA. T cell antigen-CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB1. Proc Natl Acad Sci USA 1990;87:5031-5
48. Behçet's Disease Research Committee of Japan. Skin hypersensitivity to streptococcal antigens and the induction of systemic symptoms by the antigens in Behçet's disease. A multicenter study. J Rheumatol 1989;16:506-11.
49. Lehner T. The role of a disorder in immunoregulation associated with herpes simplex virus type I in Behçet's disease. In: Lehner T, Barnes CG, editors. Recent advances in Behçet's disease. London: Royal Society of Medicine Services; 1986:31-6.
50. Gale RR, Ben-Bassat I. Annotation: Hybrid acute leukemia. Br J Haematol 1987;65:261-4.
51. Simmons D, Seed B. Isolation of a cDNA encoding CD33, a differentiation antigen of myeloid progenitor cells. J Immunol 1988;141:2797-800.